Tag Archives: VNDA

Top 10 Clean Energy Stocks To Invest In Right Now

Mention the word uranium and most likely weapons of mass destruction come to mind. While you can make plenty of jokes about investment returns in the event of nuclear war, choosing to diversify your portfolio with uranium mining stocks is certainly worth a closer look.

Azincourt Uranium Inc. (OTCBB: AZURF) (TSX: AAZ.V) the Canadian based resource company specializing in the strategic acquisition, exploration and development of uranium properties, recently announced that it has completed the acquisition of an option to gain an undivided 70-percent stake in a mining project in the Athabasca Basin of Saskatchewan. This allows the mining company to increase exploration and production mining in a region known to be rich in base minerals.

The significance of this is twofold: as climate change continues to be a global issue, the demand for clean energy is rising. And as demand rises, so too does the number of nuclear reactors under construction worldwide. In China alone there were 20 nuclear reactors under construction at the end of March, 2017.

Top 10 Clean Energy Stocks To Invest In Right Now: Kamada Ltd.(KMDA)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Retail stocks are in focus after the U.S. Census Bureau released monthly sales figures before the bell Tuesday. The bureau said that retail sales increased by 0.3% in April, a figure that matched trade expectations. Markets had expected consumer spending to increase, however home improvement sales were not the major factor that most expected. This was evident from The Home Depot’s earnings report. Markets are increasingly optimistic over U.S. trade negotiations with China. Chinese President Xi Jinping’s No. 1 economic advisor will visit the United States this week to continue the nation’s dialogue with America. In addition, roughly 100 companies and trade associations will be sounding off to the Trump administration about the potential impact of tariffs in the Chinese markets.
    Stocks to Watch Today: TSLA, AMZN, GS
    Amazon.com Inc. (Nasdaq: AMZN) is in focus thanks to tax policy in Seattle. On Monday, the Seattle’s City Council passed a bill that will tax Amazon and 131 other companies $275 per employee each year in order to create a fund to address homelessness in the Seattle. The tax is half what was originally proposed and remains a contentious issue for Amazon, which is the city’s biggest employer. Goldman Sachs Group (NYSE: GS) is sounding the alarm about the state of the markets. The company warned that the U.S. budget deficit is increasing while America’s unemployment rate is falling. This hasn’t occurred since the World War II. The bank believes that the combination of the two could cause the Fed to spike interest rates in the near future. This comes at a time when the Fed has already lost control of interest rates. Look for additional earnings reports from Eagle Materials Inc. (NYSE: EXP), Bitauto Holding Ltd.(Nasdaq: BITA), Virtusa Corp. (Nasdaq: VRTU), Global Eagle Entertainment Inc.(Nasdaq: ENT), and Kamada Ltd. (Nasdaq: KMDA).

    FollowMoney MorningonFacebook,Twitter, andLinkedIn.

  • [By Ethan Ryder]

    Kamada Ltd. (NASDAQ:KMDA) – Stock analysts at Jefferies Group dropped their FY2020 earnings estimates for shares of Kamada in a research report issued on Tuesday, May 15th. Jefferies Group analyst R. Denhoy now anticipates that the biotechnology company will earn $0.61 per share for the year, down from their previous forecast of $0.62. Jefferies Group also issued estimates for Kamada’s FY2021 earnings at $0.36 EPS.

  • [By Lisa Levin]

    Kamada Ltd. (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $24.02 million.

    Concordia International Corp. (NASDAQ: CXRX) is estimated to report quarterly earnings at $0.06 per share on revenue of $143.80 million.

Top 10 Clean Energy Stocks To Invest In Right Now: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $22.40.

Top 10 Clean Energy Stocks To Invest In Right Now: AU Optronics Corp(AUO)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Corning Incorporated in a largely steady uptrend since we recommended the stock while Universal Display Corporation (NASDAQ: OLED) skyrocketed last yearand LG Display Co Ltd (NYSE: LPL) and AU Optronics Corp (NYSE: AUO) have not done much:

Top 10 Clean Energy Stocks To Invest In Right Now: Patrick Industries, Inc.(PATK)

Advisors’ Opinion:

  • [By Logan Wallace]

    Trexquant Investment LP bought a new stake in shares of Patrick Industries, Inc. (NASDAQ:PATK) in the 1st quarter, HoldingsChannel.com reports. The fund bought 8,360 shares of the construction company’s stock, valued at approximately $517,000.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By ]

    LCI Industries (LCII) fell 5% on the day. Patrick Industries Inc. (PATK) dropped 4.24%. Thor Industries Inc. (THO) tanked 9.83%. Winnebago Industries Inc. (WGO) fell 8.85%. 

  • [By Max Byerly]

    News stories about Patrick Industries (NASDAQ:PATK) have trended positive recently, according to Accern Sentiment. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Patrick Industries earned a news sentiment score of 0.36 on Accern’s scale. Accern also gave news articles about the construction company an impact score of 48.3121750669942 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Stephan Byrd]

    Glen Harbor Capital Management LLC cut its position in shares of Patrick Industries, Inc. (NASDAQ:PATK) by 58.5% during the first quarter, HoldingsChannel.com reports. The firm owned 7,106 shares of the construction company’s stock after selling 10,030 shares during the period. Glen Harbor Capital Management LLC’s holdings in Patrick Industries were worth $439,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Clean Energy Stocks To Invest In Right Now: Qiagen N.V.(QGEN)

Advisors’ Opinion:

  • [By Brian Orelli]

    Qiagen (NYSE:QGEN), the molecular testing and lab supply company, started the year off with growth at the low end of its yearly guidance,although the first-quarter sales number was in line with where management expected to start the year.

  • [By Ethan Ryder]

    These are some of the media headlines that may have effected Accern Sentiment’s scoring:

    Get Coty alerts:

    Accused Bigamist from San Angelo is On the Run Again (sanangelolive.com) Cosmetics Manufacturer Coty Takes Retail Space in Times Square (commercialobserver.com) Analyzing Colgate-Palmolive (CL) and Coty (COTY) (americanbankingnews.com) 3 Movers of Yesterday- Coty Inc. (NYSE:COTY), Alphabet Inc. (NASDAQ:GOOG), QIAGEN NV (NYSE:QGEN) (journalfinance.net) Trending Hot Stock’s Analysis Coty Inc. (NYSE:COTY) (nasdaqjournal.com)

    A number of research firms recently commented on COTY. BMO Capital Markets raised their price objective on shares of Coty from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, February 9th. JPMorgan Chase raised their price objective on shares of Coty from $15.00 to $17.00 and gave the company an “underweight” rating in a research note on Monday, February 12th. Citigroup raised their price objective on shares of Coty from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Barclays set a $20.00 price objective on shares of Coty and gave the company a “hold” rating in a research note on Saturday, February 10th. Finally, Stifel Nicolaus reiterated a “buy” rating on shares of Coty in a research note on Friday, February 9th. Five analysts have rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $19.71.

  • [By Joseph Griffin]

    Qiagen (NYSE: QGEN) is one of 91 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its peers? We will compare Qiagen to related companies based on the strength of its valuation, profitability, risk, dividends, analyst recommendations, institutional ownership and earnings.

Top 10 Clean Energy Stocks To Invest In Right Now: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Rockwell Medical (RMTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Rockwell Medical (RMTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Dynatronics (NASDAQ: DYNT) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings.

Top 10 Clean Energy Stocks To Invest In Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Lee Jackson]

    This top company is a favorite across Wall Street.Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is a biopharmaceutical company that identifies, develops and commercializes pharmaceutical products for various medical needs in the United States, Europe and elsewhere. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology.

  • [By Max Byerly]

    Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Friday.

  • [By Logan Wallace]

    Swiss National Bank trimmed its holdings in shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) by 13.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 192,000 shares of the specialty pharmaceutical company’s stock after selling 29,100 shares during the quarter. Swiss National Bank owned 0.32% of Jazz Pharmaceuticals worth $28,990,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Keith Speights]

    But at least three of the biotechs singled out by the FDA deserve to be on another list — investors’ buy lists. Here’s why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    So which biotechnology stocks do we think are smart buys right now? We asked these three Motley Fool investors — all healthcare experts — to weigh in, and they pickedVertex Pharmaceuticals (NASDAQ:VRTX), Jazz Pharmaceuticals (NASDAQ:JAZZ), andNeurocrine Biosciences (NASDAQ:NBIX).

Top 10 Clean Energy Stocks To Invest In Right Now: Sociedad Quimica y Minera S.A.(SQM)

Advisors’ Opinion:

  • [By Beth McKenna]

    While FMC’s lithium business is only a small part of its total business, it’squite large relative to other industry players. Most industry experts peg the companyas the fourth or fifth largest producer of lithium in the world, behind Albemarle(NYSE:ALB) and Sociedad Quimica y Minera de Chile, or SQM(NYSE:SQM)– both of which also have businesses other than lithium –and China’s Ganfeng. China’s Tianqi was neck and neck with FMC for No. 4, according to an estimate from a few years ago by lithium expert Joe Lowry, who runs Global Lithium LLC.

  • [By Jim Robertson]

    Morgan Stanley analysts had issued a report predicting that the cost of the lithium could fall 45% by 2021 and they also downgraded key lithium producers Albemarle Corporation (NYSE: ALB) and Chiles Sociedad Quimica y Minera de Chile (NYSE: SQM) to “underweight” from “equal weight.

  • [By Jim Robertson]

    Earlier this week, senior commercial vice president Daniel Jimenez of Sociedad Quimica y Minera de Chile (NYSE: SQM)told delegates at Industrial Minerals’ and Metal Bulletin’s inaugural Battery Materials conference in Shanghai that there is a legitimate concern on the side of electric vehicle (EV)manufacturers over the reliability of lithium supply sources and that the industry has shown poor track record of delivering projects on time. Jimenez also commented:

  • [By Jim Robertson]

    It should be noted that FMC Corp together with Albemarle Corporation (NYSE: ALB) and Chiles Sociedad Quimica y Minera de Chile (NYSE: SQM) forma so-called lithium oligopoly that tends to dominate global production. A recent Bloomberg article noted that Albemarle Chief Executive Officer Luke Kissam had said in March that hes also eager to see how the value settles for the FMC lithium spinoff. Iftheprice-to-earnings ratio is high enough,then they would look to create a pure-play lithium business byselling off non-lithium units. If FMC Corp and Albemarle Corporation do end upcompletingthese spin-offs, thatwill be good news for the valuations of all lithium players as the market will put clear valuation numbers onthese larger pure play lithium businesses which will help provide valuation benchmarks for other small cap lithium players.

Top 10 Clean Energy Stocks To Invest In Right Now: Zogenix, Inc.(ZGNX)

Advisors’ Opinion:

  • [By Sean Williams]

    The other concern is that while it may be the first to market in treating Dravet syndrome and Lennox-Gastaut syndrome, another experimental therapy is nipping at its heels. In September, Zogenix (NASDAQ:ZGNX) announced surprisingly strong phase 3 data for ZX008, a low-dose fenfluramine that absolutely blew away the placebo in Dravet syndrome patient testing. Zogenix’s lead compound led to a 72.4% reduction in convulsive seizure frequency over a 14-week period, compared to the 17.4% reduction for placebo patients.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Zogenix (ZGNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams]

    Back in September, drug developer Zogenix (NASDAQ:ZGNX) announced data from ZX008 in late-stage trials that absolutely wowed Wall Street. ZX008, which is a low-dose fenfluramine, led to a 72.4% reduction in seizure frequency from baseline over a 14-week testing period. This compared very favorably with a 17.4% reduction in seizure frequency from baseline observed with the placebo.

Top 10 Clean Energy Stocks To Invest In Right Now: Trimble Navigation Limited(TRMB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Neuberger Berman Group LLC cut its position in shares of Trimble Inc. (NASDAQ:TRMB) by 0.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 646,355 shares of the scientific and technical instruments company’s stock after selling 4,136 shares during the quarter. Neuberger Berman Group LLC’s holdings in Trimble were worth $23,200,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

Vanda Pharmaceuticals Inc. (VNDA) Given Consensus Recommendation of “Buy” by Analysts

Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $22.40.

Several brokerages have weighed in on VNDA. Seaport Global Securities reissued a “buy” rating and set a $21.00 price target on shares of Vanda Pharmaceuticals in a research report on Wednesday, February 28th. BidaskClub raised shares of Vanda Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Wednesday, February 21st. Oppenheimer set a $27.00 price target on shares of Vanda Pharmaceuticals and gave the company a “buy” rating in a research report on Monday, March 5th. ValuEngine raised shares of Vanda Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Saturday, May 12th. Finally, Zacks Investment Research cut shares of Vanda Pharmaceuticals from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 10th.

Get Vanda Pharmaceuticals alerts:

Shares of Vanda Pharmaceuticals opened at $17.15 on Thursday, Marketbeat reports. The firm has a market capitalization of $875.46 million, a PE ratio of -49.00 and a beta of 1.12. Vanda Pharmaceuticals has a 52-week low of $16.80 and a 52-week high of $17.05.

Vanda Pharmaceuticals (NASDAQ:VNDA) last announced its quarterly earnings results on Wednesday, May 2nd. The biopharmaceutical company reported $0.06 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.17) by $0.23. The business had revenue of $43.59 million during the quarter, compared to analysts’ expectations of $43.30 million. Vanda Pharmaceuticals had a negative net margin of 2.84% and a negative return on equity of 3.06%. The firm’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.11) EPS. analysts forecast that Vanda Pharmaceuticals will post -0.05 earnings per share for the current fiscal year.

In related news, insider Mihael Hristos Polymeropoulos sold 60,966 shares of the stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $18.72, for a total value of $1,141,283.52. Following the completion of the transaction, the insider now directly owns 1,243,838 shares in the company, valued at approximately $23,284,647.36. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Gunther Birznieks sold 8,525 shares of the stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $18.72, for a total transaction of $159,588.00. Following the completion of the transaction, the senior vice president now owns 148,366 shares of the company’s stock, valued at $2,777,411.52. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 78,023 shares of company stock valued at $1,460,591. Corporate insiders own 7.60% of the company’s stock.

Several institutional investors have recently modified their holdings of VNDA. Schwab Charles Investment Management Inc. increased its stake in Vanda Pharmaceuticals by 2.0% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 482,012 shares of the biopharmaceutical company’s stock valued at $7,327,000 after purchasing an additional 9,496 shares in the last quarter. Strs Ohio increased its stake in Vanda Pharmaceuticals by 27.4% during the 4th quarter. Strs Ohio now owns 56,200 shares of the biopharmaceutical company’s stock valued at $854,000 after purchasing an additional 12,100 shares in the last quarter. Birchview Capital LP increased its stake in Vanda Pharmaceuticals by 29.4% during the 4th quarter. Birchview Capital LP now owns 88,000 shares of the biopharmaceutical company’s stock valued at $1,338,000 after purchasing an additional 20,000 shares in the last quarter. Cadence Capital Management LLC increased its stake in Vanda Pharmaceuticals by 74.2% during the 4th quarter. Cadence Capital Management LLC now owns 109,074 shares of the biopharmaceutical company’s stock valued at $1,658,000 after purchasing an additional 46,468 shares in the last quarter. Finally, Teacher Retirement System of Texas bought a new stake in Vanda Pharmaceuticals during the 4th quarter valued at about $209,000. Institutional investors own 78.79% of the company’s stock.

Vanda Pharmaceuticals Company Profile

Vanda Pharmaceuticals Inc, a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. The company's marketed products include HETLIOZ (tasimelteon), a product for the treatment of non-24-hour sleep-wake disorders; and Fanapt (iloperidone), a product for the treatment of schizophrenia.

Analyst Recommendations for Vanda Pharmaceuticals (NASDAQ:VNDA)

Top Casino Stocks To Watch Right Now

Federal investigators have halted an alleged student loan debt relief scam that bilked more than $11 million from consumers nationwide.

Strategic Student Solutions and several related companies falsely promised to reduce or eliminate student loan debt and also offered the borrowers non-existent credit repair services, in exchange for upfront fees and monthly payments, the Federal Trade Commission charged incourt papersmade public Thursday.

Although borrowers allegedly got no relief from their debts, Dave Green, owner of the companies, used corporate funds to pay for jewelry, casino tabs, mortgage payments, luxury vehicles and construction of a pool, the FTC charged.

.oembed-asset-link { border-bottom: 1px solid #e1e1e1; } .oembed-link-anchor { display: block; clear: both; } p.oembed-link-desc { font-size: 100%; color: #666; font-weight: normal; margin: 0 14px 14px 14px; font-family: ‘Futura Today Light’; text-align: left; line-height: 120%; }

FTC Complaint v Strategic Student Solutions

Top Casino Stocks To Watch Right Now: ClubCorp Holdings, Inc.(MYCC)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of ClubCorp Holdings Inc. (NYSE:MYCC) jumped 15.7% Thursday after reports stating the private golf and country-club specialist is considering strategic alternatives.

Top Casino Stocks To Watch Right Now: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Casino Stocks To Watch Right Now: iShares Intermediate Credit Bond (CIU)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of ARKANSAS FINANCIAL GROUP, INC.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ARKANSAS+FINANCIAL+GROUP%2C+INC.

    These are the top 5 holdings of ARKANSAS FINANCIAL GROUP, INC.SPDR Dow Jones Industrial Average (DIA) – 257,721 shares, 25.79% of the total portfolio. Shares added by 0.48%iShares Core S&P Mid-Cap (IJH) – 269,365 shares, 22.36% of the total portfolio. Shares added by 0.51%iShares 1-3 Year Credit Bond (CSJ) – 375,399 shares, 19.16% of the total portfolio. Shares added by 8.03%iShares Intermediate Credit Bond (CIU) – 258,147 shares, 13.64% of the total portfolio. Shares added by 1.50%Vanguard Mid-Cap ETF – DNQ (VO)

Top Growth Stocks For 2018

Sarasota, FL, based Investment company Cumberland Advisors Inc buys Guggenheim S&P 500 Equal Weight, iShares Transportation Average, SPDR Select Sector Fund – Industrial, Materials Select Sector SPDR, iShares MSCI Chile Capped Investable Market Index , SPDR S&P Regional Banking, SPDR S&P Insurance, Guggenheim S&P 500 Top 50, iShares Edge MSCI Min Vol Emerging Markets, sells PowerShares QQQ Trust Series 1, iShares North American Tech-Multimedia Networking, ALPS Sector Dividend Dogs, Vanguard Small-Cap Growth, iShares Core S&P Small-Cap during the 3-months ended 2017-09-30, according to the most recent filings of the investment company, Cumberland Advisors Inc. As of 2017-09-30, Cumberland Advisors Inc owns 40 stocks with a total value of $153 million. These are the details of the buys and sells.

New Purchases: IYT, XLI, ECH, EEMV, Added Positions: RSP, XLB, KRE, KIE, XLG, Reduced Positions: QQQ, IGN, VBK, XLK, DVY, KBWB, SCZ, IHI, AAXJ, IBB, Sold Out: SDOG, IJR, UPRO, EPD, ETP,

For the details of CUMBERLAND ADVISORS INC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=CUMBERLAND+ADVISORS+INC

Top Growth Stocks For 2018: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top Growth Stocks For 2018: Allot Communications Ltd.(ALLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Telecommunications services shares gained around 0.98 percent in trading on Thursday. Meanwhile, top gainers in the sector included Telefonica S.A. (ADR) (NYSE: TEF), and Allot Communications Ltd (NASDAQ: ALLT).

Top Growth Stocks For 2018: Kering S.A. (PPRUF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Kering Group (OTC:PPRUF), which operates the Gucci and YSL brands, said on February 10 that 2016 saw a same-store sales increase of 11 percent in Asia ex-Japan, which was mostly led by a rebound in China. LVMH, which owns brands such as Louis Vuitton, Bulgari, and Hennessy, also highlighted positive momentum going forward in its fourth-quarter earnings call with investors. Hugo Boss Group’s mainland China same-store sales also increased close to 20 percent during 2016, adjusted for currency.

Best Heal Care Stocks For 2018

Did the labor market rebound after adding just 98,000 jobs in March?

Thats the question this weeks economic news will answer. Most analystsbelieve job growth resumed its solid pace, but another disappointing showing would raise concerns about the economys health after the anemic first-quarter growth reported by the government on Friday.

Meanwhile, the Federal Reserve isnt expected to raise interest rates at a meeting that concludes Wednesday, but could give clues about a June hike. The week also features data on consumer spending, manufacturing and service-sector activity.

Consumer spending was sluggish in January and February, largely because unusually warm weather crimped demand for utilities. But March was snowier and colder in the Midwest and Northeast, and Nomura economist Lewis Alexander expects a sharp recovery in heating usage. At the same time, a core measure of retail sales picked up smartly as consumers received delayed tax refunds but auto sales continued to drop. Overall, economists expect the Commerce Department to report Monday that consumer spending rose a modest 0.2% in March.

Best Heal Care Stocks For 2018: Chesapeake Energy Corporation(CHK)

Advisors’ Opinion:

  • [By Chris Lange]

    And Chesapeake Energy Corp. (NYSE: CHK) is expected to report its most recent quarterly results on Thursday. The consensus estimates call for $0.15 in EPS and $2.3 billion in revenue. Shares closed trading at $5.06 on Friday, in a 52-week range of $4.38 to $8.20. The consensus price target is $5.36.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Chesapeake Energy Corp. (NYSE: CHK) which traded down 3.2% at $6.12. The stocks 52-week range is $3.54 to $8.20. Volume was roughly 76.8 million versus the daily average of 38.3 million shares.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Treehouse Foods (THS) , TG Therapeutics (TGTX) , Kinder Morgan (KMI) , Magellan Midstream Partners (MMP) , Chesapeake Energy (CHK) and Arconic (ARNC) .

Best Heal Care Stocks For 2018: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Best Heal Care Stocks For 2018: Neometals Ltd (RRSSF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].